» Articles » PMID: 20956325

Bacillus Anthracis Produces Membrane-derived Vesicles Containing Biologically Active Toxins

Overview
Specialty Science
Date 2010 Oct 20
PMID 20956325
Citations 198
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular vesicle production is a ubiquitous process in Gram-negative bacteria, but little is known about such process in Gram-positive bacteria. We report the isolation of extracellular vesicles from the supernatants of Bacillus anthracis, a Gram-positive bacillus that is a powerful agent for biological warfare. B. anthracis vesicles formed at the outer layer of the bacterial cell had double-membrane spheres and ranged from 50 to 150 nm in diameter. Immunoelectron microscopy with mAbs to protective antigen, lethal factor, edema toxin, and anthrolysin revealed toxin components and anthrolysin in vesicles, with some vesicles containing more than one toxin component. Toxin-containing vesicles were also visualized inside B. anthracis-infected macrophages. ELISA and immunoblot analysis of vesicle preparations confirmed the presence of B. anthracis toxin components. A mAb to protective antigen protected macrophages against vesicles from an anthrolysin-deficient strain, but not against vesicles from Sterne 34F2 and Sterne δT strains, consistent with the notion that vesicles delivered both toxin and anthrolysin to host cells. Vesicles were immunogenic in BALB/c mice, which produced a robust IgM response to toxin components. Furthermore, vesicle-immunized mice lived significantly longer than controls after B. anthracis challenge. Our results indicate that toxin secretion in B. anthracis is, at least, partially vesicle-associated, thus allowing concentrated delivery of toxin components to target host cells, a mechanism that may increase toxin potency. Our observations may have important implications for the design of vaccines, for passive antibody strategies, and provide a previously unexplored system for studying secretory pathways in Gram-positive bacteria.

Citing Articles

Recent advances in bacterial outer membrane vesicles: Effects on the immune system, mechanisms and their usage for tumor treatment.

Xiang S, Khan A, Yao Q, Wang D J Pharm Anal. 2025; 14(12):101049.

PMID: 39840399 PMC: 11750273. DOI: 10.1016/j.jpha.2024.101049.


Identifying plasma exosome antigens as a potential diagnostic biomarker for tuberculosis disease.

Jiang Y, Yan L, Zhou B, Hong J, Tan H, Li X BMC Infect Dis. 2025; 25(1):65.

PMID: 39815174 PMC: 11734573. DOI: 10.1186/s12879-025-10474-9.


Unveiling the promise: Exosomes as game-changers in anti-infective therapy.

Chavda V, Luo G, Bezbaruah R, Kalita T, Sarma A, Deka G Exploration (Beijing). 2024; 4(5):20230139.

PMID: 39439498 PMC: 11491308. DOI: 10.1002/EXP.20230139.


Aerobic adaptation and metabolic dynamics of DSM 20271: insights from comparative transcriptomics and surfaceome analysis.

Loivamaa I, Sillanpaa A, Deptula P, Chamlagain B, Edelmann M, Auvinen P mSystems. 2024; 9(10):e0061524.

PMID: 39345151 PMC: 11494915. DOI: 10.1128/msystems.00615-24.


Overview of extracellular vesicles in pathogens with special focus on human extracellular protozoan parasites.

Alvarado-Ocampo J, Abrahams-Sandi E, Retana-Moreira L Mem Inst Oswaldo Cruz. 2024; 119:e240073.

PMID: 39319874 PMC: 11421424. DOI: 10.1590/0074-02760240073.


References
1.
Rodrigues M, Nimrichter L, Oliveira D, Frases S, Miranda K, Zaragoza O . Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot Cell. 2006; 6(1):48-59. PMC: 1800364. DOI: 10.1128/EC.00318-06. View

2.
Fiocca R, Necchi V, Sommi P, Ricci V, Telford J, Cover T . Release of Helicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicles. Uptake of released toxin and vesicles by gastric epithelium. J Pathol. 1999; 188(2):220-6. DOI: 10.1002/(SICI)1096-9896(199906)188:2<220::AID-PATH307>3.0.CO;2-C. View

3.
Abboud N, De Jesus M, Nakouzi A, Cordero R, Pujato M, Fiser A . Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies. J Biol Chem. 2009; 284(37):25077-86. PMC: 2757211. DOI: 10.1074/jbc.M109.022061. View

4.
Rivera J, Nakouzi A, Abboud N, Revskaya E, Goldman D, Collier R . A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1. Infect Immun. 2006; 74(7):4149-56. PMC: 1489699. DOI: 10.1128/IAI.00150-06. View

5.
Collier R, Young J . Anthrax toxin. Annu Rev Cell Dev Biol. 2003; 19:45-70. DOI: 10.1146/annurev.cellbio.19.111301.140655. View